TX Dallas의 전이성 암 임상 시험
전이성 암 관련 연구 42개가 Dallas 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
피험자 모집 중2상
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- UT Southwest Simmons Cancer Center, Dallas
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
피험자 모집 중1상
- Texas Oncology, Dallas
- University of Texas Southwestern Medical Center, Dallas
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
피험자 모집 중1상
- UT Southwestern, Dallas
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
피험자 모집 중1상
- SCRI at Mary Crowley, Dallas
- University of Texas Southwestern Medical Center, Dallas
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
피험자 모집 중2/3상
- Texas Oncology- Baylor Charles A. Sammons Cancer Center, Dallas
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
피험자 모집 중1/2상
- The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
피험자 모집 중3상
- Texas Oncology - DFW, Dallas
- Texas Oncology - DFW, Dallas
- Texas Oncology - DFW, Dallas
- 외 2개
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
피험자 모집 중2/3상
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- 외 1개
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
피험자 모집 중1상
- NEXT Oncology, Dallas
- SCRI at Mary Crowley, Dallas
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
피험자 모집 중3상
- Research Site, Dallas
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
피험자 모집 중2상
- University of Texas Southwestern Medical Center, Dallas
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
피험자 모집 중3상
- Parkland Health and Hospital System, Dallas
- UT Southwestern Medical Center, Dallas
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
피험자 모집 중3상
- Parkland Health and Hospital System, Dallas
- USO - Texas Oncology, Dallas
- UT Southwestern Medical Center, Dallas
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
피험자 모집 중1상
- Texas Oncology - DFW (Sammons CC), Dallas
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
피험자 모집 중3상
- UT Southwestern Medical Center, Dallas
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
피험자 모집 중1/2상
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Simmons Cancer Center - Redbird, Dallas
- 외 2개
A Study of KK2269 in Adult Participants With Solid Tumors
피험자 모집 중1상
- The University of Texas Southwestern Medical Center, Dallas
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Clinical Study Site, Dallas
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
피험자 모집 중1/2상
- Avenzo Therapeutics Recruiting Site, Dallas
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
피험자 모집 중3상
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- Mary Crowley Cancer Research, Dallas
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
피험자 모집 중1상
- University of Texas Southwestern Medical Center, Dallas
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
피험자 모집 중1상
- University of Texas Southwestern, Dallas
- Texas Oncology, P.A, Dallas
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Mary Crowley Cancer Research, Dallas
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
A Study of ASP1002 in Adults for Treatment of Solid Tumors
피험자 모집 중1상
- Mary Crowley Cancer Research Center, Dallas
A Study of PYX-201 in Advanced Solid Tumors
피험자 모집 중1상
- NEXT Dallas, Dallas
Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung
피험자 모집 중초기 1상
- University of Texas Southwestern Medical Center, Dallas
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
피험자 모집 중3상
- Old Parkland Hospital Hematology Oncology Clinic, Dallas
- UT Southwestern Medical Center, Dallas
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
피험자 모집 중1상
- Sarah Cannon Research Institute at Mary Crowley, Dallas
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
피험자 모집 중1상
- Sarah Cannon Research Institute at Mary Crowley, Dallas
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
피험자 모집 중1/2상
- Mary Crowley Cancer Research, Dallas
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
피험자 모집 중2/3상
- UT Southwestern Medical Center, Dallas
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
피험자 모집 중1/2상
- Next Oncology, Dallas
- UTSW Medical Center, Dallas
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- NEXT Dallas, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- NEXT Oncology - Dallas, Dallas
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
피험자 모집 중1상
- Mary Crowley Cancer Research, Dallas
- Baylor University Medical Center, Dallas
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
피험자 모집 중1상
- Urology Clinics of North Texas, Dallas
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
피험자 모집 중1상
- Texas Oncology - Baylor Charles A Sammons Cancer Center, Dallas
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
피험자 모집 중2상
- University of Texas Southwestern Medical Center, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Dallas
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
피험자 모집 중1/2상
- Mary Crowley Cancer Research, Dallas
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
피험자 모집 중1상
- Texas Oncology, Dallas
다른 도시의 전이성 암 시험
- Houston, TX연구 104개
- New York City, NY연구 93개
- Nashville, TN연구 70개
- Boston, MA연구 63개
- Los Angeles, CA연구 57개
- St. Louis, MO연구 54개
- Arlington, VA연구 53개
- Philadelphia, PA연구 46개
- Chicago, IL연구 45개
- San Antonio, TX연구 44개
- Washington, DC연구 43개
- Seattle, WA연구 39개
Dallas의 다른 연구
- 유방암연구 55개
- 비소세포폐암연구 52개
- 심부전연구 42개
- 암 (전체)연구 37개
- 전립선암연구 36개
- 대장직장암연구 33개
- 비만연구 30개
- 난소암연구 28개
- 방광암연구 27개
- 폐암연구 27개
- 자궁내막암연구 24개
- 심혈관 질환연구 23개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.